Related Experiment Video
Updated: Aug 4, 2025

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
Neurologic Complications of Patients With COVID-19 Requiring Extracorporeal Membrane Oxygenation: A Systematic Review
Cathy Meng Fei Li1,2, Xiaoxiao Densy Deng2, Yu Fei Ma3
1Department of Clinical Neurological Sciences, Western University, London, ON, Canada.
Insights
Patients with COVID-19 needing extracorporeal membrane oxygenation (ECMO) frequently experience intracranial hemorrhage (ICH). Neurologic complications significantly increase mortality risk in these critically ill patients.
Area of Science:
- Neurology
- Critical Care Medicine
- Infectious Diseases
Background:
- Severe COVID-19 often necessitates extracorporeal membrane oxygenation (ECMO).
- Neurologic complications are a significant concern in ECMO patients.
- Intracranial hemorrhage (ICH) is a potential complication in this population.
Purpose of the Study:
- To determine the frequency of intracranial hemorrhage (ICH) in COVID-19 patients on ECMO.
- To assess the incidence of ischemic stroke and the association between anticoagulation and ICH.
- To evaluate the impact of neurologic complications on in-hospital mortality.
Main Methods:
- Systematic review and meta-analysis of studies published up to March 15, 2022.
- Inclusion of adult patients with SARS-CoV-2 infection requiring ECMO.
- Random-effects model used for meta-analysis of pooled data.
Main Results:
- The frequency of ICH was 11% in patients on venovenous ECMO, with intraparenchymal hemorrhage most common.
- Ischemic stroke occurred in 2% of patients; higher anticoagulation targets did not correlate with increased ICH.
- In-hospital mortality was 37%, and neurologic complications more than doubled mortality risk (RR 2.24).
Conclusions:
- COVID-19 patients on venovenous ECMO face a high risk of ICH.
- Neurologic complications substantially elevate the risk of death in this cohort.
- Clinicians must maintain vigilance for ICH in ECMO-supported COVID-19 patients.
Abstract:
In COVID-19 patients requiring extracorporeal membrane oxygenation (ECMO), our primary objective was to determine the frequency of intracranial hemorrhage (ICH). Secondary objectives were to estimate the frequency of ischemic stroke, to explore association between higher anticoagulation targets and ICH, and to estimate the association between neurologic complications and in-hospital mortality.
Data Sources:
We searched MEDLINE, Embase, PsycINFO, Cochrane, and MedRxiv databases from inception to March 15, 2022.
Study Selection:
We identified studies that described acute neurological complications in adult patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection requiring ECMO.
Data Extraction:
Two authors independently performed study selection and data extraction. Studies with 95% or more of its patients on venovenous or venoarterial ECMO were pooled for meta-analysis, which was calculated using a random-effects model.
Data Synthesis:
Fifty-four studies (n = 3,347) were included in the systematic review. Venovenous ECMO was used in 97% of patients. Meta-analysis of ICH and ischemic stroke on venovenous ECMO included 18 and 11 studies, respectively. The frequency of ICH was 11% (95% CI, 8-15%), with intraparenchymal hemorrhage being the most common subtype (73%), while the frequency of ischemic strokes was 2% (95% CI, 1-3%). Higher anticoagulation targets were not associated with increased frequency of ICH (p = 0.06). In-hospital mortality was 37% (95% CI, 34-40%) and neurologic causes ranked as the third most common cause of death. The risk ratio of mortality in COVID-19 patients with neurologic complications on venovenous ECMO compared with patients without neurologic complications was 2.24 (95% CI, 1.46-3.46). There were insufficient studies for meta-analysis of COVID-19 patients on venoarterial ECMO.
Conclusions:
COVID-19 patients requiring venovenous ECMO have a high frequency of ICH, and the development of neurologic complications more than doubled the risk of death. Healthcare providers should be aware of these increased risks and maintain a high index of suspicion for ICH.
More Related Videos
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Pneumonia III: Complications and Assessment
Acute Respiratory Failure-III
Hemodialysis II: Procedure and Complications
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

